Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Multicenter Study of Allogenic, Intracerebroventricular Human Neural Stem Cells Transplantation for the Experimental Treatment of Secondary Progressive Multiple Sclerosis Patients

NCT03282760 is registered in ClinicalTrials.gov with Casa Sollievo della Sofferenza IRCCS as lead sponsor.

NCT NCT03282760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Multicenter Study of Allogenic, Intracerebroventricular Human Neural Stem Cells Transplantation for the Experimental Treatment of Secondary Progressive Multiple Sclerosis Patients
Lead sponsor
Casa Sollievo della Sofferenza IRCCS
Phase
Phase 1
Overall status
Completed
Start date
September 9, 2017
Completion date
May 29, 2021
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

secondary-progressive multiple sclerosis